(Q40224903)

English

Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function

scientific article published on 2 October 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

0 references

0 references

cannabinoid receptor

0 references

protein heterodimerization activity

1 reference

based on heuristic

inferred from title

author name string

James Ellis

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

John D Pediani

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Meritxell Canals

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sandra Milasta

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Graeme Milligan

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

2 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

281

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

38812-38824

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

GPCR dimerisation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

G protein-coupled receptor dimerization: function and ligand pharmacology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Dopamine D2 receptor dimer formation: evidence from ligand binding

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Oligomers of D2 dopamine receptors: evidence from ligand binding

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

The G protein-coupled receptor repertoires of human and mouse

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Global analysis of G-protein-coupled receptor signaling in human tissues

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

The angiotensin II AT2 receptor is an AT1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Cannabinoid CB1 receptors control conditioned drug seeking

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Rimonabant--a selective CB1 antagonist

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Endocannabinoid receptor antagonists: potential for obesity treatment

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Orexins and the treatment of obesity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Sleep, feeding, and neuropeptides: roles of orexins and orexin receptors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

The role of hypocretins (orexins) in sleep regulation and narcolepsy.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Hypocretins (orexins) and sleep-wake disorders

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Interactions between the Mas-related receptors MrgD and MrgE alter signalling and trafficking of MrgD.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Up-regulation of the angiotensin II type 1 receptor by the MAS proto-oncogene is due to constitutive activation of Gq/G11 by MAS

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Multiple interactions between transmembrane helices generate the oligomeric alpha1b-adrenoceptor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Activation mechanism of the heterodimeric GABA(B) receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Allosteric functioning of dimeric class C G-protein-coupled receptors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Constitutive endocytic cycle of the CB1 cannabinoid receptor.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Orexins and appetite regulation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

A role for lateral hypothalamic orexin neurons in reward seeking

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Cannabinoid receptor homo- and heterodimerization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602494200

21 January 2018

Identifiers

10.1074/JBC.M602494200

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40224903&oldid=1889362680"